Postmortem, in silico, and clinical studies focused on perturbations of glutamate neurobiology in schizophrenia

Schizophr Res. 2022 Nov:249:1-3. doi: 10.1016/j.schres.2022.07.020. Epub 2022 Sep 8.

Authors

Robert E McCullumsmith¹, Laura M Rowland²

Affiliations

¹ Department of Neurosciences, University of Toledo College of Medicine and Life Sciences, Toledo, OH, USA; Neurosciences Institute, ProMedica, Toledo, OH, USA. Electronic address: Robert.mccullumsmith@utoledo.edu.
² Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland Baltimore, Baltimore, MD, USA.

PMID: 36088176
DOI: 10.1016/j.schres.2022.07.020

No abstract available

Publication types

Research Support, N.I.H., Extramural

MeSH terms

Autopsy
Brain
Glutamic Acid
Humans
Neurobiology
Schizophrenia*

Substances

Glutamic Acid